Evaluation of Drug Recognition Expert Reports in Marijuana Cases Brianna Peterson, Ph.D. and Rod Gullberg, M.S. Washington State Patrol September 20, 2011.

Slides:



Advertisements
Similar presentations
Drug Evaluation and Classification NHTSA National Roadside Survey 2.2% of the drivers impaired by alcohol 16.3% nighttime weekend drivers impaired.
Advertisements

Drug Identification.
Drugs are classified by the effects they have on the body and mind.
PRACTICAL SOLUTIONS TO TOXICOLOGY ISSUES IN DUI CASES Brianna Peterson, PhD, DABFT Toxicology Laboratory Division Washington State Patrol.
Marijuana Myths & Realities. Who is using marijuana? Marijuana Use8 th 9th12th Past Month 0-5% % % 6-10.
Introduction to Drugged Driving. What is a “Drug”? Working Definition of “Drug: – Any substance that, when taken into the human body, can impair the ability.
Drugs & Poisons.
Minnehaha County Sheriff’s Office Explorer Post #11.
Vital signs. Types Temperature Pulse Respirations Blood pressure (Degree of pain)
Diagnostic Procedures & Pharmacology
Urine Marijuana Analysis and Interpretation Dan Coleman California Department of Justice.
Blood Pressure Heart Rate What is it? The force the heart exerts against the walls of arteries as it pumps the blood out to the body The number of times.
Drugs & Poisons.
 Some drugs are more harmful than others  If you use a drug, over time you can develop a tolerance to it.  Tolerance- body’s need for larger and larger.
Drug and Alcohol Impaired Driving Drug and Alcohol Impaired Driving Troopers Desmond Watson and Isaac Kurtz.
Role of the DRE Detective Sergeant Stacy Moate, WSP Bellevue CID
Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws M.M. Bergamaschi, E.L. Karschner, R.S.
What is a DRE? Tony Corroto DRE/SFST Instructor DRE/SFST
Health Mrs. Wagner.  1. Depressant – decreases CNS – Alcohol  2. Hallucinogens – Distorts reality – LSD, Ecstasy, PCP  3. Inhalants – Take in fumes.
DRE 12 Step Process. The Drug Influence Evaluation Systematic and Standardized Process The DEC procedure is a systematic and standardized method of examining.
The Science & Admissibility of Drug Evaluation and Classification Evidence Drug Recognition Expert.
Cannabinoid Concentrations Detected in Fatal Road Traffic Collision Victims Compared with a Population of Other Post Mortem Cases R. Andrews, K.G. Murphy,
DWI Detection Phases  Vehicle in Motion Initial observation of vehicle Initial observation of vehicle Observation of stopping sequence Observation of.
Drug Recognition Expert (DRE)  12-Step Standardized and Systematic Process for evaluating persons suspected of being under the influence of drugs.  A.
Traffic Safety Lt.Garry Scott Vermont State Police Traffic Safety Unit.
MARIJUANA. Most commonly used illegal drug Psychoactive Drug 6.8% of high school students admit to using marijuana in the last month 69 Million Americans.
Basic Drug Recognition for Parents Brian Kozak Avon Police Department.
May 2016 An Evaluation of Data from Drivers Arrested for Driving Under the Influence in Relation to Per se Limits for Cannabis.
Drug Classification.
Drug Impaired Driving: A Toxicologist Perspective Bruce A. Goldberger, Ph.D. Division of Forensic Medicine Departments of Pathology and Psychiatry University.
Judge Neil Edward Axel District Court of Maryland (retired) Heidi Coleman Chief, Behavioral Research, NHTSA Office of Behavioral Safety Research Maryland.
May 2016 Cannabis Use among Drivers Suspected of Driving Under the Influence or Involved in Collisions: Analysis of Washington State Patrol Data.
CHAPTER THIRTEEN LESSON SEVEN MARIJUANA. OBJECTIVES DESCRIBE THE EFFECTS OF MARIJUANA. IDENTIFY THE DANGERS OF USING MARIJUANA.
Drug impaired driving AAMVA Region IV Conference June 21, 2011.
Jennifer L. Doherty, MS, LAT, ATC Management of Medical Emergencies
Psychoactive Drugs Chemicals that: Affect the nervous system
60 Minutes Session 2 Overview of the Drug Evaluation and Classification Procedures.
60 Minutes Session 2 Overview of the Drug Evaluation and Classification Procedures Revised: 01/2015 Drug Evaluation and Classification (Prelim) Drug Evaluation.
The DRE Program and Drug Impaired Driving
Assessing Eye Signs Detecting Signs of Drug Influence
Impact of legalized recreational marijuana in Washington State
85 Minutes Session 21 Cannabis.
Mr. Fisher SUBSTANCE ABUSE.
Poly-substance Impaired Drivers
Short term effects of alcohol
Standardized Field Sobriety Testing Review
MARYLAND DRE Program & Challenges
Session 30 Transition to the Certification Phase of Training
105 Minutes Session 12 Alcohol Workshop.
Drug Recognition Expert Course
90 Minutes Session 4 The Eye Examinations.
Review of the DRE School
North Dakota Nurses Association
Session 4 Overview of Drug Recognition Expert Procedures 150 Minutes
110 Minutes Session 24 Drug Combinations.
Drug Recognition Expert Course
Cannabis.
Drug-Impaired Driving Investigation
DRE Submit Applications Officer ethics Background Report writing
Drug trends: The Vermont perspective
105 Minutes Session 8 Demonstrations of the Evaluation Sequence.
90 Minutes Session 27 Practice: Test Administration.
Drug Abuse © 2004 Pearson Education, Inc..
Forensic Science Ch. 5: Drugs
The study of Drugs and Poisons
Health Chapter 22.
Detecting Drug Impaired Drivers
WHAT TO DO TO PREPARE FOR TODAY’S LESSON
Doug Beirness Amy Porath D’Arcy Smith Erin Beasley
Presentation transcript:

Evaluation of Drug Recognition Expert Reports in Marijuana Cases Brianna Peterson, Ph.D. and Rod Gullberg, M.S. Washington State Patrol September 20, 2011

Goal of study Determine if DRE indicators for cannabis are present in cases with THC detectedDetermine if DRE indicators for cannabis are present in cases with THC detected Compare indicators for subjects with active THC versus THC-COOH onlyCompare indicators for subjects with active THC versus THC-COOH only

size Horizontal Gaze Nystagmus Vertical Gaze Nystagmus Lack of Convergence Pupil Reaction to light Pulse Blood Pressure Body Temp Depressants Inhalants Dissociative Anesthetics Stimulants Hallucinogens Narcotic Analgesics Cannabis Present None Present None Present None Normal Dilated Constricted Slow NormalSlowNormalLittle to none DownUp Down Up/Down Up Down NormalUp/Down /Normal Up None Present Dilated Normal Up NormalUp Down DRE Matrix

DRE indicators for cannabis category Lack of convergence (LOC) presentLack of convergence (LOC) present Pupil size normal to dilatedPupil size normal to dilated Elevated pulse rateElevated pulse rate Elevated blood pressureElevated blood pressure Horizontal gaze nystagmus (HGN) not presentHorizontal gaze nystagmus (HGN) not present Vertical nystagmus (VGN) not presentVertical nystagmus (VGN) not present Reaction to light is normalReaction to light is normal Body temperature is normalBody temperature is normal

THC pharmacokinetics Highly lipid solubleHighly lipid soluble Short half-lifeShort half-life –3 hrs post smoking, THC in serum <5 ng/mL Main metabolite: 11-nor-9 carboxy-THC (THC-COOH)Main metabolite: 11-nor-9 carboxy-THC (THC-COOH)

Methodology DRE cases from ; blood sample analyzedDRE cases from ; blood sample analyzed Tested for volatiles by Headspace Gas ChromatographyTested for volatiles by Headspace Gas Chromatography EMIT drug screenEMIT drug screen –Cannabinoids cut off = 10 ng/mL THC-COOH THC confirmation by GC/MS (SIM mode)THC confirmation by GC/MS (SIM mode) –Limits of Detection THC = 1.0 ng/mLTHC = 1.0 ng/mL THC-COOH = 5.0 ng/mLTHC-COOH = 5.0 ng/mL Cases that were only positive for THC or THC-COOH

Subjects THC/THC-COOH (n=101)THC/THC-COOH (n=101) –93% male –78% Caucasian –Average age: 24 (range: 16-70) THC-COOH only (n=147)THC-COOH only (n=147) –79% male –84% Caucasian –Average age: 27 (range: 14-61) Not impaired (n=17)Not impaired (n=17) –76% male –94% caucasian –Average age: 38 (range: 19-74)

147 THC/THC-COOH cases Mean = 74.1; median = 61.7 Mean = 7.3; median = THC-COOH only cases Mean = 16.6; median = 13.5Results

Lack of convergence *p=0.003

Normal range: 2.5 – 5.0 mm Average pupil size: Room light 56%, 61% above normal range

Average pupil size: Dark Normal range: mm 60%, 58% above normal range

Average pupil size: Direct light 49%, 47% above normal range Normal range: 2.0 – 4.5 mm

Average pulse Normal range = bpm 57% above normal range

Systolic blood pressure Normal range = 120 – 140 mm Hg 45% above normal range

Body Temperature Normal range = 98.6 ± 1°F 73, 87% in normal range

Not impaired: 17 cases from Summary Cannabis indicator THC/THC- COOH THC- COOH Not impaired HGNNone9%11%6% VGNNone02%0 Lack of convergencePresent66%47%6% PupilSizeNormal to dilated 55% 15% Reactionto lightNormal76%77%82% PulseElevated57% 25% Blood pressure (Systolic/diastolic) Elevated45%/22%45%/25%41%/12% Body TemperatureNormal73%87%77%

Summary THC/THC- COOH THC-COOH Bloodshoteyes Eyelidtremors 2/8 clues on WAT 2/4 clues on OLS Not impaired 86%81%24% 81% 38% 72%81%25% 46%57%31%

Other indicators Romberg test: estimation of 30 secondsRomberg test: estimation of 30 seconds –Normal range = 25 to 35 seconds THC/THC-COOHTHC-COOHNot impaired 60%51%47%

Other indicators Rebound DilationRebound Dilation Reaction to lightReaction to light –Normal, slow, little THC/THC-COOHTHC-COOHNot impaired 43%41%6% THC/THC-COOHTHC-COOHNot impaired 77%76%82%

DRE Opinion THC/THC-COOH casesTHC/THC-COOH cases –97% DRE called cannabis Other cases called ‘not impaired’Other cases called ‘not impaired’ –98% subject admitted to marijuana use THC-COOH only casesTHC-COOH only cases –97% DRE called cannabis Stimulant/not impairedStimulant/not impaired –88% subject admitted to marijuana use

Conclusions DRE matrix is useful tool for predicting marijuana useDRE matrix is useful tool for predicting marijuana use Similar indicators for THC/THC-COOH and THC-COOH casesSimilar indicators for THC/THC-COOH and THC-COOH cases –Short half-life, long exam process

Beasley et al. study Examined which indicators best predict substance (n =742)Examined which indicators best predict substance (n =742) Stimulants versus cannabisStimulants versus cannabis –Stimulants: less reddening of eyes and rebound dilation, more likely to have hippus, injection sites, slow reaction to light –Cannabis: more likely to have lack of convergence Toward a More Parsimonious Approach to Drug Recognition Expert Evaluations. Traffic Injury Prevention 2009;10:

Acknowledgments Rod GullbergRod Gullberg –Research Analyst, Washington State Patrol